Evaluation of bioequivalence of loratadine capsules in healthy volunteers

ZHANG Xian-zhou,MENG Shu-fang,ZHU Hong-da,LIU Gang,WANG Hui,ZHANG Ling-li,LUO Shun-de
DOI: https://doi.org/10.3321/j.issn:1001-5213.2007.10.019
2007-01-01
Abstract:OBJECTIVE To evaluate the bioequivalence of loratadine capsules in Chinese healthy volunteers.METHODSA single oral dose 40 mg of two loratadine preparations,reference and test preparation was given to 20 volunteers in a randomized cross-over study.The concentration of loratadine in plasma was determined by solid phase extract HPLC.RESULTSThe main pharmacokinetic parameters of two preparations reference and test preparations were as follows:AUC0-∞were(57.3±20.7) and(60.1±23.7)μg·h·L-1,AUC0-8were(56.5±20.8) and(59.2±23.8)μg·h·L-1,Cmax were(22.9±5.1) and (22.9±5.4)μg·L-1,tmaxwere(0.93±0.20) and(1.06±0.25)h,tmaxwere(1.3±0.4) and(1.2±0.4)h,respectively.The relative bioavailability was(105.0±12.3)%.CONCLUSIONThe results of two one-side test statistical analysis show that the two formulations are bioequivalent.
What problem does this paper attempt to address?